Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $212M invested in Corvus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 13 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
22
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EC
1
EcoR1 Capital
San Francisco,
California
|
$9.74M |
2 |
2
Jennison Associates
New York
|
$12.3M |
3 |
BI
3
BVF Inc
San Francisco,
California
|
$3.32M |
4 |
4
BlackRock
New York
|
$4.47M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$4.03M |